company background image
4574 logo

Taiko PharmaceuticalLtd TSE:4574 Stock Report

Last Price

JP¥322.00

Market Cap

JP¥16.2b

7D

2.5%

1Y

5.6%

Updated

31 Jan, 2025

Data

Company Financials +

Taiko Pharmaceutical Co.,Ltd.

TSE:4574 Stock Report

Market Cap: JP¥16.2b

4574 Stock Overview

Manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. More details

4574 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Earnings are forecast to grow 60.1% per year

Risk Analysis

No risks detected for 4574 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Taiko Pharmaceutical Co.,Ltd. Competitors

SEEDLtd

TSE:7743

JP¥15.2b

JMSLtd

TSE:7702

JP¥10.9b

Koken

TSE:7963

JP¥7.7b

Create Medic

TSE:5187

JP¥7.9b

Price History & Performance

Summary of share price highs, lows and changes for Taiko PharmaceuticalLtd
Historical stock prices
Current Share PriceJP¥322.00
52 Week HighJP¥495.00
52 Week LowJP¥285.00
Beta0.12
1 Month Change-2.72%
3 Month Change-15.49%
1 Year Change5.57%
3 Year Change-51.51%
5 Year Change-75.51%
Change since IPO15.00%

Recent News & Updates

Recent updates

Is Taiko PharmaceuticalLtd (TSE:4574) A Risky Investment?

Mar 08
Is Taiko PharmaceuticalLtd (TSE:4574) A Risky Investment?

Taiko Pharmaceutical Co.,Ltd. (TSE:4574) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 08
Taiko Pharmaceutical Co.,Ltd. (TSE:4574) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Shareholder Returns

4574JP Medical EquipmentJP Market
7D2.5%0.3%1.2%
1Y5.6%11.0%8.4%

Return vs Industry: 4574 underperformed the JP Medical Equipment industry which returned 11% over the past year.

Return vs Market: 4574 underperformed the JP Market which returned 8.4% over the past year.

Price Volatility

Is 4574's price volatile compared to industry and market?
4574 volatility
4574 Average Weekly Movement3.3%
Medical Equipment Industry Average Movement3.3%
Market Average Movement3.5%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 4574 has not had significant price volatility in the past 3 months compared to the JP market.

Volatility Over Time: 4574's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1946208Takashi Shibatawww.seirogan.co.jp

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation.

Taiko Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Taiko PharmaceuticalLtd's earnings and revenue compare to its market cap?
4574 fundamental statistics
Market capJP¥16.16b
Earnings (TTM)-JP¥2.33b
Revenue (TTM)JP¥6.28b

2.6x

P/S Ratio

-6.9x

P/E Ratio

Is 4574 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4574 income statement (TTM)
RevenueJP¥6.28b
Cost of RevenueJP¥2.78b
Gross ProfitJP¥3.50b
Other ExpensesJP¥5.84b
Earnings-JP¥2.33b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)-46.52
Gross Margin55.73%
Net Profit Margin-37.17%
Debt/Equity Ratio27.7%

How did 4574 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 03:15
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taiko Pharmaceutical Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masatoshi NagataIchiyoshi Research Institute Inc.
Kenji SakaiMizuho Securities Co., Ltd.
Yukichi OkabeOkasan Securities Co. Ltd.